These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cadaver kidney transplantation in Turkey. Haberal M; Demirağ A; Cohen B; Turan M; Erdoğan H; Arslan G; Bilgin N Transplant Proc; 1995 Oct; 27(5):2768-9. PubMed ID: 7482907 [No Abstract] [Full Text] [Related]
4. Comparison of immunosuppressive protocols in renal transplantation: a multicenter view. Opelz G Transplant Proc; 1988 Dec; 20(6 Suppl 8):31-6. PubMed ID: 3059620 [No Abstract] [Full Text] [Related]
5. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
6. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration. Laine J; Hoppu K; Holmberg C Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874 [No Abstract] [Full Text] [Related]
7. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens. Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684 [No Abstract] [Full Text] [Related]
8. Is withdrawal of steroids hazardous to cadaveric renal transplants under treatment with cyclosporine? Hillebrand G; Krumme D; Schleibner S; Land W; Gurland HJ Transplant Proc; 1988 Jun; 20(3 Suppl 3):126-9. PubMed ID: 3291225 [No Abstract] [Full Text] [Related]
9. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
10. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression. Schweizer RT; Bow L; Roper L; Hull D; Bartus SA Clin Transpl; 1988; ():147-58. PubMed ID: 3154467 [TBL] [Abstract][Full Text] [Related]
11. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss. Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216 [No Abstract] [Full Text] [Related]
12. Immunosuppressive regimens and their effects on renal allograft outcome. Katznelson S; Cecka JM Clin Transpl; 1996; ():361-71. PubMed ID: 9286582 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months. Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521 [TBL] [Abstract][Full Text] [Related]
14. Clinical study and experience in cadaveric kidney transplantation for 15 years. Lixin Y; Xiwen B; Junjie M Transplant Proc; 1996 Jun; 28(3):1568-70. PubMed ID: 8658788 [No Abstract] [Full Text] [Related]
16. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP Clin Transpl; 1996; ():257-64. PubMed ID: 9286575 [TBL] [Abstract][Full Text] [Related]
17. Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens. Dandavino R; Barcelo R; Beaudry C; Cardinal J; Carriere S; Friborg J; Houde M; Ouimet D; Bastien E; Girard R; Laplante L Transplant Proc; 1982 Dec; 14(4):635-9. PubMed ID: 6762720 [No Abstract] [Full Text] [Related]
18. Steroid withdrawal in kidney transplant recipients: is it a safe option? Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950 [TBL] [Abstract][Full Text] [Related]
19. Kidney graft loss in children: implications for program development. Crocker JF; Wade AW; McDonald AT; McLellan DH; Lawen JG; Bitter-Suermann H; Acott PD CMAJ; 1998 Aug; 159(3):229-35. PubMed ID: 9724976 [TBL] [Abstract][Full Text] [Related]
20. Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch. Hong JH; Sadeghian M; Sumrani N; Cacciarelli TV; Distant DA; Sommer BG; Norin AJ Transplant Proc; 1996 Jun; 28(3):1340-1. PubMed ID: 8658685 [No Abstract] [Full Text] [Related] [Next] [New Search]